CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Z Squared Inc (Delaware) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Z Squared Inc (Delaware)
105 Bradford Road, Suite 420
Phone: (302) 636-5400p:302 636-5400 WEXFORD, PA  15090  United States Ticker: ZSQRZSQR
Business Summary
Z Squared, Inc. is a vertically integrated computing infrastructure company operating advanced computing equipment strategically distributed across North Carolina, South Carolina, and Iowa. The Company's operations include crypto mining, which provides a foundation for its verticals in power generation, data center development, and high-performance compute hosting. The Company manages and optimizes a fleet of specialized computing hardware, supported by power management strategies, real-time analytics dashboards, and a comprehensive in-house repair and life cycle management program. The Company's infrastructure supports agile redeployment of equipment based on shifting power costs, infrastructure readiness, and uptime performance. The Company is focused on responding to real-time grid conditions, including curtailment schedules and seasonal electricity rate fluctuations.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chief Executive Officer, Director MichelleBurke 40 4/27/2026 4/24/2026
Co-Chief Executive Officer, Director DavidHalabu 49 4/27/2026 4/24/2026
Chief Financial Officer BrianCogley 39 5/1/2023 5/1/2023
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Coeptis Pharmaceuticals, Inc. 105 Bradford Rd Wexford PA United States
Coeptis Therapeutics, Inc. 105 Bradford Rd, Suite 420 WEXFORD PA United States

Business Names
Business Name
BHSE
BHSEU
COEP
14 additional Business Names available in full report.

General Information
Number of Employees: 4 (As of 12/31/2025)
Outstanding Shares: 51,431,493 (As of 4/24/2026)
Shareholders: 128
Stock Exchange: NASD
Federal Tax Id: 981465952
Fax Number: (302) 636-5454


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, May 18, 2026